<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">24578</article-id><article-id pub-id-type="doi">10.7554/eLife.24578</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title><italic>PTEN</italic> controls glandular morphogenesis through a juxtamembrane <italic>β-Arrestin1/ARHGAP21</italic> scaffolding complex</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-92512"><name><surname>Javadi</surname><given-names>Arman</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-65158"><name><surname>Deevi</surname><given-names>Ravi K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-79005"><name><surname>Evergren</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-79006"><name><surname>Blondel-Tepaz</surname><given-names>Elodie</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-47950"><name><surname>Baillie</surname><given-names>George S</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-67241"><name><surname>Scott</surname><given-names>Mark GH</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1557-1856</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-59133"><name><surname>Campbell</surname><given-names>Frederick Charles</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0363-9964</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Centre for Cancer Research and Cell Biology</institution>, <institution>Queen's University of Belfast</institution>, <addr-line><named-content content-type="city">Belfast</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Inserm, U1016</institution>, <institution>Institut Cochin</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">Institute of Cardiovascular and Medical Science</institution>, <institution>University of Glasgow</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1040"><name><surname>Balasubramanian</surname><given-names>Mohan K</given-names></name><role>Reviewing editor</role><aff><institution>University of Warwick</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>f.c.campbell@qub.ac.uk</email> (FC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>07</month><year>2017</year></pub-date><volume>6</volume><elocation-id>e24578</elocation-id><history><date date-type="received"><day>23</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>07</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Javadi et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Javadi et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-24578-v1.pdf"/><abstract><p><italic>PTEN</italic> controls three-dimensional (3D) glandular morphogenesis by coupling juxtamembrane signalling to mitotic spindle machinery. While molecular mechanisms remain unclear, <italic>PTEN</italic> interacts through its C2 membrane-binding domain with the scaffold protein <italic>β-Arrestin1</italic>. Because <italic>β-Arrestin1</italic> binds and suppresses the <italic>Cdc42</italic> GTPase-activating protein <italic>ARHGAP21</italic>, we hypothesize that <italic>PTEN</italic> controls <italic>Cdc42</italic>-dependent morphogenic processes through a <italic>β-Arrestin1-ARHGAP21</italic> complex. Here we show that <italic>PTEN</italic> knockdown (KD) impairs <italic>β-Arrestin1</italic> membrane localization, <italic>β-Arrestin1-ARHGAP21</italic> interactions, <italic>Cdc42</italic> activation, mitotic spindle orientation and 3D glandular morphogenesis. Effects of <italic>PTEN</italic>-deficiency were phenocopied by <italic>β-Arrestin1</italic> KD or inhibition of <italic>β-Arrestin1-ARHGAP21</italic> interactions. Conversely, silencing of <italic>ARHGAP21</italic> enhanced <italic>Cdc42</italic> activation and rescued aberrant morphogenic processes of <italic>PTEN</italic>-deficient cultures. Expression of the <italic>PTEN</italic> C2 domain mimicked effects of full-length <italic>PTEN</italic> but a membrane-binding defective mutant of the C2 domain abrogated these properties. Our results show that <italic>PTEN</italic> controls multicellular assembly through a membrane-associated regulatory protein complex composed of <italic>β-Arrestin1</italic>, <italic>ARHGAP21</italic> and <italic>Cdc42</italic>.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C9136/A15342</award-id><principal-award-recipient><name><surname>Campbell</surname><given-names>Frederick Charles</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008302</institution-id><institution>Department of Education and Learning, Northern Ireland</institution></institution-wrap></funding-source><award-id>Studentship</award-id><principal-award-recipient><name><surname>Javadi</surname><given-names>Arman</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004097</institution-id><institution>Fondation ARC pour la Recherche sur le Cancer</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Scott</surname><given-names>Mark GH</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MRC(MR/J007412/1)</award-id><principal-award-recipient><name><surname>Baillie</surname><given-names>George S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec sec-type="supplementary-material"><supplementary-material><ext-link xlink:href="elife-24578-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>